Showing results (61-70 of 311) with videos related to

Sort By:
Pageof 32
Brain : a Journal of Neurology|December 10, 2015
Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodiesAnne Stuendl, Marcel Kunadt, Niels Kruse, et al.
Nature Communications|June 18, 2024
Plasma proteomics identify biomarkers predicting Parkinson's disease up to 7 years before symptom onsetJenny Hällqvist, Michael Bartl, Mohammed Dakna, et al.
Molecular and Cellular Neurosciences|June 6, 2022
The relevance of synuclein autoantibodies as a biomarker for Parkinson's diseasePretty Garg, Fabian Maass, Sivaraj M Sundaram, et al.
Dementia and Geriatric Cognitive Disorders|December 8, 2010
Cerebrospinal fluid tau, p-tau 181 and amyloid-β38/40/42 in frontotemporal dementias and primary progressive aphasiasMirko Bibl, Brit Mollenhauer, Piotr Lewczuk, et al.
Neuroscience Letters|November 15, 2012
Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjectsBrit Mollenhauer, Ellen Trautmann, Peggy Taylor, et al.
Journal of Clinical Laboratory Analysis|July 20, 2012
Plasma amyloid-beta peptides in acute cerebral ischemia: a pilot studyMirko Bibl, Volker Welge, Holger Schmidt, et al.
Dementia and Geriatric Cognitive Disorders|October 28, 2006
Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob diseaseLukas Cepek, Peter Brechlin, Petra Steinacker, et al.
Journal of Neurochemistry|January 5, 2022
Detection and quantification of Aβ-3-40 (APP669-711) in cerebrospinal fluidHans-Wolfgang Klafki, Oliver Wirths, Brit Mollenhauer, et al.
Pageof 32